002773:SHE
Chengdu Kanghong Pharma Grp Co Ltd
19,44 CNY
arrow_downward
-1,92%(-0,38) 1D
16 ოქტ, 15:04:09 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 002773...
Open
20,34 CNY
High
20,34 CNY
Low
19,30 CNY
Mkt. cap
18,61 მლრდ.
Avg. vol.
7,30 მლნ.
Volume
6,59 მლნ.
Dividend
3,60%
Quarterly dividend
0,17 CNY
Ex-dividend date
9 ივნ. 2026
P/E ratio
18,00
52-wk high
36,10 CNY
52-wk low
18,62 CNY
EPS
1,08 CNY
Shares outstanding
921,33 მლნ.
No. of employees
4 ათ.
Open
20,34 CNY
High
20,34 CNY
Low
19,30 CNY
Mkt. cap
18,61 მლრდ.
Avg. vol.
7,30 მლნ.
Volume
6,59 მლნ.
Dividend
3,60%
Quarterly dividend
0,17 CNY
Ex-dividend date
9 ივნ. 2026
P/E ratio
18,00
52-wk high
36,10 CNY
52-wk low
18,62 CNY
EPS
1,08 CNY
Shares outstanding
921,33 მლნ.
No. of employees
4 ათ.
News stories
From web sources and news partners
medwatch.com
·
58 წუთის წინ
Iambic Therapeutics raises USD 150m in Nasdaq IPO
The Globe and Mail
·
33 წუთის წინ
TNL Mediagene Regains Compliance with Nasdaq Minimum Bid Price Requirement
CNBC
·
28 წუთის წინ
S&P 500 futures are little changed as index heads for losing week
Yahoo Finance
·
18 წუთის წინ
SPDR Dow Jones Industrial Average ETF (DIA) Sells $31.3 Million More Goldman Sachs on Oct. 14
Profile
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion.
As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
About Chengdu Kanghong Pharma Grp Co Ltd